Home > Newsletters > FDAnews Drug Daily Bulletin > House Passes PDUFA, Corrects Generics/Biosimilars User Fee Glitch
FDAnews Drug Daily Bulletin
June 22, 2012 | Vol. 9 No. 123
House Passes PDUFA, Corrects Generics/Biosimilars User Fee Glitch
The House Wednesday overwhelmingly approved reauthorizing the Prescription Drug User Fee Act (PDUFA), sending it on to the Senate with a voice vote. The House left intact the reconciled version of the bill, the FDA Safety and Innovation Act, S. 3187, that was ironed out between Senate and House negotiators on Monday.
Drug Industry Daily
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.